Introduction {#sec1-1}
============

Ectopic pregnancy (EP) is a dangerous complication during early pregnancy. Pioneer studies have found that both previous EP and *in vitro* fertilization and embryo transfer (IVF-ET) are risk factors for EP recurrence.[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9][@ref10] Thus, it can be speculated that women with EP histories who undergo IVF-ET have a higher risk of EP recurrence than other women. In general, there are three ways to cope with EP--medical treatment by methotrexate (MTX) injection, radical surgery (salpingectomy), and conservative surgery (salpingostomy).[@ref11] Many studies have investigated the influence of different EP treatment methods on pregnancy. Previous studies have reported that there was no significant difference in subsequent spontaneous fertility following different EP treatments.[@ref11][@ref12] However, in two other studies, it was determined that conservative surgery is superior to radical surgery at preserving fertility.[@ref13][@ref14] However, few studies have investigated the effects of the three main EP treatments on IVF-ET outcomes. According to current clinical knowledge, the cryopreserved embryo transfer (CET) cycle can significantly decrease the EP rate in IVF-ET.[@ref7][@ref10][@ref15][@ref16] In this study, we discuss the effect of different treatment methods on the recurrence risk of EP in CET cycles.

Materials and methods {#sec1-2}
=====================

Patients {#sec2-1}
--------

This retrospective cohort study was performed at the Center for Reproduction, Shandong University, Jinan, China. Our analysis of the data was approved by the Institutional Review Board of Shandong University. A total of 1333 women with previous histories of being admitted to the hospital for CET treatment were consecutively enrolled between January 2009 and December 2014. The method for identifying patients and assigning groups are shown in [Figure 1](#F1){ref-type="fig"}. The authors already had access to identifying information during data collection.

![Database searching pathway and group divisions of women with ectopic pregnancy histories. CET = cryopreserved embryo transfer.](GMIT-6-103-g001){#F1}

All embryos were transferred in autologous cycles, and all outcomes were derived from the first CET cycle. We categorized the women into four groups based on the treatment methods used and whether the connection between the fallopian tubes and uterus had been severed. The women in Group 1 underwent unilateral removal surgery, and the women in Group 2 underwent bilateral tubal removal or unilateral tubal removal with contralateral tubal ligation. These women received ligation/removal of the contralateral tube because of a ruptured tubal ectopic pregnancy or serious adhesion and hydronephrosis. The women in Group 3 underwent conservative surgery (salpingostomy), and the women in Group 4 underwent conservative medical treatment with MTX and/or other drugs, such as Chinese herbal medicine and mifepristone, without any abdominal surgery. The outcome rates, including ectopic pregnancy rate, clinical pregnancy rate, delivery rate, miscarriage rate, implantation rate, and ongoing pregnancy rate, were calculated according to the methods described in our former study.[@ref17]

Because patients in Groups 1, 3, and 4 had at least one fallopian tube, we compared pregnancy outcomes among them and compared data from Groups 1 and 2 separately.

The exclusion criteria were as follows: (1) the previous EP did not result from a natural pregnancy; (2) repeated implantation failure (underwent more than 3 cycles but did not become pregnant); (3) oocyte donor treatment cycles; and (4) the presence of other diseases, such as chromosome abnormalities, malignant intracavitary lesions, and a history of myomectomy. The baseline characteristics of the women studied are shown in [Table 1](#T1){ref-type="table"}.

###### 

Outcomes of cryopreserved embryo transfer in four groups.

  Items     EPR            DR                CPR               MR              IR                OPR
  --------- -------------- ----------------- ----------------- --------------- ----------------- -----------------
  Group 1   3/473 (0.63)   247/473 (52.22)   302/473 (63.85)   42/473 (8.88)   366/750 (48.80)   272/473 (57.51)
  Group 2   0/260 (0)      139/260 (53.46)   159/260 (61.15)   9/260 (3.46)    204/420 (48.57)   154/260 (59.23)
  Group 3   6/435 (1.38)   218/435 (50.11)   271/435 (62.30)   38/435 (8.74)   343/722 (47.51)   239/435 (54.94)
  Group 4   0/159 (0)      86/159 (54.09)    99/159 (62.26)    9/159 (5.66)    131/262 (50.00)   90/159 (56.60)

Values are presented as*n* (%).

CPR = clinical pregnancy rate; DR = delivery rate; EPR = ectopic pregnancy rate; IR = implantation rate; MR = miscarriage rate; OPR = ongoing pregnancy rate.

Statistical analysis {#sec2-2}
--------------------

Statistical analysis was conducted using SPSS version 19.0 (SPSS Inc., Chicago, IL, USA). The normally distributed data were expressed as mean ± standard deviation. The categorical data and the quantitative data were analyzed by χ^2^ tests and *t* tests, respectively. A *p* value \< 0.05 was considered statistically significant. We used Cox regression to calculate the odds ratios (ORs) and 95% confidence intervals (CI) to investigate the associations between the treatment types. Additional factors that would influence pregnancy outcomes, including age, body mass index, polycystic ovarian syndrome, mycoplasma infection, tuberculosis infection, untreated hydrosalpinx, endometrium thickness, and endometriosis, were also evaluated. In order to evaluate the results from different groups, we defined the statistical outcomes of Group 1 versus Group 3 as *p*~1~, Group 3 versus Group 4 as *p*~2~, Group 1 versus Group 4 as *p*~3~, and Group 1 versus Group 2 as *p*~4~.

Ethics statement {#sec2-3}
----------------

This study was a retrospective analysis of clinical practice outcomes, and our analysis of the data was approved by the Institutional Review Board of Shandong University. We obtained informed consent from the patients before they participated in a clinical study or experiment.

Results {#sec1-3}
=======

Unilateral tubal removal was performed in 473 women (35.48%), bilateral tubal removal or unilateral tubal removal with contralateral tubal ligation was performed in 260 women (19.50%), conservative surgery was performed in 435 women (32.63%), and conservative medication was administered to 159 women (11.93%). The baseline data are shown in [Table 2](#T2){ref-type="table"}.

###### 

Odds ratios of four groups in cryopreserved embryo transfer.

  Items   *p*                OR        95%CI   
  ------- ------------------ --------- ------- -------
  EPR     *p*~1~ = 0.258     0.456     0.113   1.836
          *p*~2~ = 0.137     0.986     0.975   0.997
          *p*~3~ = 0.314     0.994     0.987   1.001
          *p*~4~ = 0.198     0.994     0.987   1.001
  DR      *p*~1~ = 0.526     1.088     0.838   1.412
          *p*~2~ = 0.391     0.853     0.592   1.227
          *p*~3~ = 0.683     0.928     0.647   1.330
          *p*~4~ = 0.747     0.951     0.703   1.288
  CPR     *p*~1~ = 0.629     1.069     0.816   1.400
          *p*~2~ = 0.994     1.001     0.688   1.457
          *p*~3~ = 0.720     1.070     0.738   1.552
          *p*~4~ = 0.470     1.122     0.821   1.533
  MR      *p*~1~ = 0.939     1.018     0.643   1.612
          *p*~2~ = 0.219     1.595     0.753   3.379
          *p*~3~ = 0.197     1.624     0.772   3.416
          *p*~4~ = 0.006\*   2.718\*   1.301   5.677
  IR      *p*~1~ = 0.620     1.053     0.858   1.292
          *p*~2~ = 0.489     0.905     0.682   1.201
          *p*~3~ = 0.738     0.953     0.719   1.263
          *p*~4~ = 0.940     1.009     0.795   1.282
  OPR     *p*~1~ = 0.437     1.110     0.854   1.443
          *p*~2~ = 0.718     0.935     0.648   1.348
          *p*~3~ = 0.842     1.037     0.722   1.491
          *p*~4~ = 0.651     0.931     0.685   1.267

\* Statistical significance.

CI = confidence interval; CPR = clinical pregnancy rate; DR = delivery rate; EPR = ectopic pregnancy rate; IR = implantation rate; MR = miscarriage rate; OPR = ongoing pregnancy rate; OR = odds ratio; *p*~1~ = Group 1 vs. Group 3; *p*~2~ = Group 3 vs. Group 4; *p*~3~ = Group 1 vs. Group 4; *p*~4~ = Group 1 vs. Group2.

Among the 1333 women who attempted to conceive again, 831 (62.34%) were clinical pregnant after CET cycles. Of these pregnancies, 9 (1.08%) were EPs, 690 (83.03%) were delivered (term and preterm births), and 98 (11.79%) were miscarried. The pregnancy outcomes in the four groups are as follows.

After a crude analysis, the EP rates were 0.63%, 1.38%, and 0% for Groups 1, 3, and 4, respectively. Although there was no statistically significant differences among the three groups (*p*~1~ = 0.258, 95% CI = 0.113--1.836; *p*~2~ = 0.137, 95%CI = 0.975--0.997; *p*~3~ = 0.314, 95% CI = 0.987--1.001), conservative surgery resulted in the highest EP rate, and OR was 0.456 (95%CI = 0.113--1.836) for Groups 1 and 3 regarding EP. The implantation rates were 48.40%, 47.51%, and 50.00% for Groups 1, 3, and 4, respectively. Group 4 had the highest implantation rate, but this rate was not significantly different among the groups (*p*~1~ = 0.620, 95%CI = 0.858--1.292; *p*~2~ = 0.489, 95%CI = 0.682--1.201; *p*~3~ = 0.738, 95%CI = 0.719--1.263). We reached the same finding when we compared delivery rates, clinical pregnancy rates, miscarriage rates, and ongoing pregnancy rates among the three groups. The detailed results are shown in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

###### 

Main characteristics in the four groups.

  Items            Age (y)            Body mass index   Polycystic ovarian syndrome   Mycoplasma infection   Tuberculosis infection   Hydrosalpinx untreated   Endometrium thickness (cm)   Endometriosis
  ---------------- ------------------ ----------------- ----------------------------- ---------------------- ------------------------ ------------------------ ---------------------------- ----------------
  Group 1          31.07 ± 4.218      23.19 ± 3.41      50/473 (10.57)                165/473 (33.88)        7/473 (1.48)             43/487 (8.83)            0.97 ± 1.60                  6/473 (1.27)
  Group 2          31.26 ± 4.130      23.20 ± 3.51      21/260 (8.08)                 97/260 (37.30)         8/260 (3.08)             --                       0.96 ± 1.57                  3/260 (1.15)
  Group 3          30.59 ± 3.994      22.83 ± 3.07      58/435 (13.33)                160/435 (36.78)        18/435 (4.14)            49/429 (11.42)           0.97 ± 1.60                  6/435 (1.38)
  Group 4          31.11 ± 3.823      23.44 ± 3.43      28/159 (17.61)                59/159 (37.11)         2/159 (1.26)             18/159 (11.46)           0.98 ± 1.52                  2/159 (1.26)
  *p*              *p*~1~ = 0.080     *p*~1~ = 0.094    *p*~1~ = 0.199                *p*~1~ = 0.551         *p*~1~ = 0.014           *p*~1~ = 0.193           *p*~1~ = 0.950               *p*~1~ = 0.884
  *p*~2~ = 0.159   *p*~2~ = 0.031\*   *p*~2~ = 0.190    *p*~2~ = 0.942                *p*~2~ = 0.838         *p*~2~ = 0.987           *p*~2~ = 0.686           *p*~2~ = 0.909               
  *p*~3~ = 0.922   *p*~3~ = 0.418     *p*~3~ = 0.020    *p*~3~ = 0.612                *p*~3~ = 0.085         *p*~3~ = 0.327           *p*~3~ = 0.652           *p*~3~ = 0.992               
  *p*~4~ = 0.561   *p*~4~ = 0.823     *p*~4~ = 0.275    *p*~4~ = 0.512                *p*~4~ = 0.144         --                       *p*~4~ = 0.437           *p*~4~ = 0.893               

Values are presented as mean ± standard error or *n* (%).

\* Statistical significance.

*p*~1~ = Group 1 vs. Group 3; *p*~2~ = Group 3 vs. Group 4; *p*~3~ = Group 1 vs. Group 4; *p*~4~ = Group 1 vs. Group 2.

In order to compare the effects of tubal residue, we compared Groups 1 and 2. The results showed that Group 2 had a 61.03% lower miscarriage rate (8.88% vs. 3.46%, *p* = 0.006) than the Group 1, suggesting that the residual tube is a risk factor for miscarriage (OR = 2.718, 95%CI = 1.301--5.677).The rate of EP was not significantly different according to the treatment type (0.63% vs. 0%, *p* = 0.137, 95%CI = 0.975--0.997). Other pregnancy outcomes were not statistically significant different among groups. The detailed results are shown in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}.

Discussion {#sec1-4}
==========

We undertook this retrospective study to determine whether different EP treatments affect CET outcomes. We found that the occurrence of EP is very low in CET cycles (9/1333, 0.675%). Tubal removal is a protective factor for conservative surgery to treat EP, and the residual tube is a risk factor for later miscarriage. There are no significant differences in delivery rates, implantation rates, and ongoing pregnancy rates among the different EP treatment groups.

We support the opinion of Horcajadas et al[@ref18] that a lower EP rate in CET cycles is associated with a negative effect on ovarian stimulation and endometrial receptivity. It has been reported that an improved endometrial environment leads to intrauterine implantation because the embryo must develop further within the uterine cavity.[@ref15]

The pregnancy outcomes among the treatment groups were not significantly different. Although ORs (OR = 0.456, 95% CI = 0.113--1.836) were slightly different between Groups 1 and 3, the statistical *p* values did not differ (*p* = 0.258). As is well known, it is difficult to avoid tubal trauma during surgery, and concurrent salpingemphraxis and hydrosalpinx are more likely to occur after surgery, which are both important factors for EP recurrence.[@ref19] However, in our data, we compared women with hydrosalpinx to keep the interference factors to a minimum ([Table 1](#T1){ref-type="table"}).We speculated that a higher incidence of EP may be related to the residual tube. The lower miscarriage rate in Group 2 (8.88% vs. 3.46%, *p* = 0.006, OR = 2.718, 95% CI = 1.301--5.677) is probably attributable to salpingitis and latent hydrosalpinx on the other side. The selective bias is another interpretation for these outcomes.

In general, the CET outcome is related to the quality of embryos, age, endometrial receptivity, and the microenvironment.[@ref20][@ref21] However, in our research, we compared these factors to keep the interference elements to a minimum. Rashid et al[@ref22] showed that the term pregnancy rates between the radical and conservative surgery treatment groups were not significantly different.[@ref13] However, Li et al[@ref23] proved that the interstitial pregnancy rate increased after laparoscopic salpingestomy. The results of our study are similar to those of Rashid et al[@ref22] in which different types of previous EP treatment did not significantly affect the main CET outcomes.

Overall, the three methods of EP treatment are used in different situations. Salpingectomy was typically performed in emergency cases in which the tube was already ruptured or the patient was critically bleeding. However, a recent opinion has speculated that salpingectomy may lead to spontaneous rupture of the pregnant uterus.[@ref24] Salpingostomy is the best conservative surgery for EP, and the main indications are that women are fertile, their vital signs are stable, and the sac diameter of the mass is \< 6 cm. Patients are excluded from this type of treatment if the tube has already ruptured or they are critically bleeding. The major argument against conservative surgery is the possibility of incomplete fetus removal and the increased risk of EP recurrence as the damaged tube is left behind. In 2012, the National Collaborating Center for Women's and Children's Health published that salpingectomy is preferred over salpingostomy, except when patients present with other infertility risks. As for conservative medical treatment, MTX is suitable for women who have a definite diagnosis or are highly suspected of ectopic pregnancy, have stable hemodynamics, and an unbroken mass (ACOG Practice Bulletin No. 94: Medical management of ectopic pregnancy). The main advantages of this method are as follows: (1) a greater antitrophoblastic effect; (2) a shorter treatment period; (3) reduced dosage; and (4) the absence of side effects.[@ref25] In 2014, it was reported that MTX treatment for EP does not seem to affect subsequent fertility treatment.[@ref26] However, incomplete abortions often occur with this method.

Tubal factor infertility was the most common indication for IVF.[@ref27] In our data, we observed a large number of women (56%) who underwent tubal ligation or removal surgery, but it is unclear whether these data are necessary to consider.

Strengths and limitations {#sec2-4}
-------------------------

Our study has some strengths as well as limitations. First, our research is valuable because 1333 women make the study a large reported sample size. Second, the cryopreservation of morula by vitrification, embryo splitting, and embryo transfer occurred in the same reproductive medicine center (Shandong Provincial Key Laboratory of Reproductive Medicine, Jinan, People's Republic of China). Thus, there are no obvious differences among culture conditions and embryo quality. Third, although many scholars have studied different EP treatments with regard to fertility or spontaneous pregnancy, we have not yet found studies that have investigated the effect of different treatments on CET cycles. Our study is innovative and credible and suggests that clinicians reconsider the management of EP before IVF.

The limitations of our research cannot be ignored. This is a retrospective study; therefore, selection bias is inescapable to some extent. The data from the four groups were all collected from the Reproductive Hospital affiliated with Shandong University and were not extracted from multiple centers. Also, the number of tubal surgeries and the degree of tubal damage were not the same. We could not control the previous EP treatments performed at other hospitals for which detailed operation methods are lacking. In addition, we collected the women's information as completely as possible; however, some individual details were possibly ignored. However, we believe these differences do not influence our conclusions.

Conclusion {#sec1-5}
==========

Different EP treatment methods have no significant impact on the main pregnancy outcomes after CET. Bilateral tubal ligation or removal surgery can decrease the miscarriage rate but does not impact other pregnancy outcomes. The tube after conservative therapy for tubal EP might be a bad prognostic factor for future successful pregnancy. Our results suggest that hydrosalpinx should be actively processed during surgery. However, EP surgery requires further detailed study.
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